BMY: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/42a00a64-f5fb-4e9d-8c04-ee21a38f04eb/","filing_uuid":"42a00a64-f5fb-4e9d-8c04-ee21a38f04eb","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/42a00a64-f5fb-4e9d-8c04-ee21a38f04eb/print/","filing_document_content_type":"text/html","income":null,"expenses":"3160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Rodger Currie","dt_posted":"2026-07-20T18:44:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Ave, NW, Suite 745","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":7053,"url":"https://lda.gov/api/v1/registrants/7053/","house_registrant_id":31580,"name":"BRISTOL-MYERS SQUIBB COMPANY","description":"Lobbying on biopharmaceutical issues.","address_1":"801 Pennsylvania Ave, NW, Suite 745","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA DAVIS EIDSON","contact_telephone":"+1 727-519-5721","dt_updated":"2026-07-30T14:10:40.000859-04:00"},"client":{"id":109642,"url":"https://lda.gov/api/v1/clients/109642/","client_id":12,"name":"BRISTOL-MYERS SQUIBB COMPANY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-05-21"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"International Reference Pricing/Most Favored Nation, including all bio-pharmaceutical issues Issues concerning competitive trade","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":76410,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"DEOUDES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146913,"prefix":null,"prefix_display":null,"first_name":"SOFIA","nickname":null,"middle_name":null,"last_name":"FOX","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146914,"prefix":null,"prefix_display":null,"first_name":"KIRBY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150789,"prefix":null,"prefix_display":null,"first_name":"RODGER","nickname":null,"middle_name":null,"last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152647,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"CALVO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36053,"prefix":null,"prefix_display":null,"first_name":"LANE","nickname":null,"middle_name":null,"last_name":"PENRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":100551,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"BRUNET","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154633,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R.1492, Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 ORPHAN Cures Act MINI Act H.R.4299, the Protecting Patient Access to Cancer and Complex Therapies Act of 2025 H.R.7391, CHC Drug Pricing Protection Act H.R.5509, Safe Step Act Issues related to biosimilars reimbursement issues Clinical Trial Modernization Act Essential medicines/Buy American regarding all bio-pharmaceutical provisions","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":100551,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"BRUNET","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150789,"prefix":null,"prefix_display":null,"first_name":"RODGER","nickname":null,"middle_name":null,"last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36053,"prefix":null,"prefix_display":null,"first_name":"LANE","nickname":null,"middle_name":null,"last_name":"PENRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146913,"prefix":null,"prefix_display":null,"first_name":"SOFIA","nickname":null,"middle_name":null,"last_name":"FOX","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146914,"prefix":null,"prefix_display":null,"first_name":"KIRBY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152647,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"CALVO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76410,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"DEOUDES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":92488,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"NOVARIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154633,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154754,"prefix":"ms","prefix_display":"MS.","first_name":"NICOLE","nickname":null,"middle_name":"ANNE","last_name":"L'ESPERANCE","suffix":null,"suffix_display":null},"covered_position":"Director/Advisor-Senate Finance Committee 2018-2025; Comms Dirctor, U.S.House 2015-2018","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions H.R.7635, the 340B PATIENTS Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150789,"prefix":null,"prefix_display":null,"first_name":"RODGER","nickname":null,"middle_name":null,"last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36053,"prefix":null,"prefix_display":null,"first_name":"LANE","nickname":null,"middle_name":null,"last_name":"PENRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":92488,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"NOVARIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146913,"prefix":null,"prefix_display":null,"first_name":"SOFIA","nickname":null,"middle_name":null,"last_name":"FOX","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76410,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"DEOUDES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152647,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"CALVO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146914,"prefix":null,"prefix_display":null,"first_name":"KIRBY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154633,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Discussions regarding OECD implementation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":76410,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"DEOUDES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36053,"prefix":null,"prefix_display":null,"first_name":"LANE","nickname":null,"middle_name":null,"last_name":"PENRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150789,"prefix":null,"prefix_display":null,"first_name":"RODGER","nickname":null,"middle_name":null,"last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152647,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"CALVO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":100551,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"BRUNET","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154633,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual Property Reform concerning bio-pharmaceutical industry","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":100551,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"BRUNET","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150789,"prefix":null,"prefix_display":null,"first_name":"RODGER","nickname":null,"middle_name":null,"last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36053,"prefix":null,"prefix_display":null,"first_name":"LANE","nickname":null,"middle_name":null,"last_name":"PENRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146913,"prefix":null,"prefix_display":null,"first_name":"SOFIA","nickname":null,"middle_name":null,"last_name":"FOX","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152647,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"CALVO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154633,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}